| Autor: |
Deisenhofer AK; University of Trier, Germany. Electronic address: deisenhofer@uni-trier.de., Barkham M; University of Sheffield, UK., Beierl ET; University of Oxford, UK., Schwartz B; University of Trier, Germany., Aafjes-van Doorn K; Yeshiva University, USA., Beevers CG; The University of Texas at Austin, USA., Berwian IM; Princeton University, USA., Blackwell SE; Ruhr University Bochum, Germany., Bockting CL; AmsterdamUMC, Department of Psychiatry, Research Program Amsterdam Public Health and Centre for Urban Mental Health, University of Amsterdam, the Netherlands., Brakemeier EL; University of Greifswald, Germany., Brown G; Royal Holloway University of London, UK., Buckman JEJ; University College London, UK., Castonguay LG; Pennsylvania State University, USA., Cusack CE; University of Louisville, USA., Dalgleish T; University of Cambridge, UK., de Jong K; Leiden University, Institute of Psychology, USA., Delgadillo J; University of Sheffield, UK., DeRubeis RJ; University of Pennsylvania, USA., Driessen E; Radboud University, USA., Ehrenreich-May J; University of Miami, USA., Fisher AJ; University of California, Berkeley, USA., Fried EI; Leiden University, USA., Fritz J; University of Cambridge, UK; Philipps University of Marburg, Germany., Furukawa TA; Kyoto University, USA., Gillan CM; School of Psychology, Trinity College Institute for Neuroscience, And Global Brain Health Institute, Trinity College Dublin, USA., Gómez Penedo JM; University of Buenos Aires, USA., Hitchcock PF; Emory University, USA., Hofmann SG; Philipps University of Marburg, Germany., Hollon SD; Vanderbilt University, USA., Jacobson NC; Dartmouth Geisel School of Medicine, USA., Karlin DR; MindMed, Inc., Tufts University School of Medicine, USA., Lee CT; Trinity College Dublin, USA., Levinson CA; University of Louisville, USA., Lorenzo-Luaces L; Indiana University-Bloomington, USA., McDanal R; Stony Brook University, USA., Moggia D; University of Trier, Germany., Ng MY; Florida International University, USA., Norris LA; Warren Alpert Medical School of Brown University, USA., Patel V; Harvard Medical School, USA., Piccirillo ML; University of Washington, USA., Pilling S; University College London, UK., Rubel JA; Osnabrück University, USA., Salazar-de-Pablo G; King's College London and South London and Maudsley NHS Foundation Trust, USA., Schleider JL; Stony Brook University and Feinberg School of Medicine Northwestern University, USA., Schnurr PP; National Center for PTSD and Geisel School of Medicine at Dartmouth, USA., Schueller SM; University of California, Irvine, USA., Siegle GJ; University of Pittsburgh, USA., Uher R; Dalhousie University, USA., Watkins E; University of Exeter, USA., Webb CA; Harvard Medical School, McLean Hospital, USA., Wiltsey Stirman S; National Center for PTSD and Stanford University, USA., Wynants L; Maastricht University, USA., Youn SJ; Reliant Medical Group, OptumCare and Harvard Medical School, USA., Zilcha-Mano S; University of Haifa, USA., Lutz W; University of Trier, Germany., Cohen ZD; University of California, Los Angeles and University of Arizona, USA. Electronic address: cohenzd@arizona.edu. |
| Abstrakt: |
Competing Interests: Declaration of competing interest Michael Barkham has co-produced outcome measures used in routine outcome monitoring and also jointly published a text on routine outcome monitoring but receives no financial payment for these activities. Christopher G. Beevers has received funding for his research from the National Institutes of Health, Brain and Behavior Foundation, Aiberry Inc., and other private, not-for-profit foundations. He has received income from the Association for Psychological Science for his editorial work and from Orexo, Inc. for serving on a Scientific Advisory Board related to digital therapeutics. Dr. Beevers' financial disclosures have been reviewed and approved by the University of Texas at Austin in accordance with its conflict-of-interest policies. Tim Dalgleish has received payment for consultancy work with Princeton Biopartners, Boehringer Ingelheim and Felix Inc. He delivers paid workshops on psychological therapies. He receives royalties for books on affect and psychological disorders. Nicholas C. Jacobson declares the following conflicts of interest. He has edited a book that includes discussion of this topic from which he receives royalties. Additionally, he has accepted paid speaking invitations from various organizations. Dr. Jacobson confirms that these interests do not influence the research, interpretation, or conclusions presented in this manuscript. Daniel R. Karlin is an employee, officer, and shareholder of MindMed; shareholder and director at Sonara Health; trustee at Trudeau Institute; shareholder and consultant to NightWare; consultant to Otsuka, Tempus, Limitless Ventures, Recovery Delivered, and 4YouandMe. Cheri A. Levinson has a financial interest in BeWell and Awaken Digital Solutions. Lorenzo Lorenzo-Luaces has received consulting fees from Syra Health who had no involvement in the current research. Stephen M. Schueller serves on the Scientific Advisory Board for Headspace for which he receives compensation and has received consulting payments from Boehringer Ingelheim, K Health (Trusst), and Otsuka Pharmaceuticals for unrelated work. Greg J. Siegle receives royalty payments on a patent regarding a vibroacoustic intervention for psychiatric conditions, licensed to Apollo Neurosciences. Wolfgang Lutz and Eva-Lotta Brakemeier initiated and chair the Interest Group "Evidence-Based Personalized Psychotherapy Research (ePePsy)" of the German Psychological Association. |
Full Text from ScienceDirect